Caffeine related disorders
|
group |
|
Mental or Behavioral Dysfunction
|
360
|
56
|
0.030 |
None |
1.000 |
3 |
|
2018 |
2019 |
Malignant neoplasm of stomach stage IV
|
disease |
|
Neoplastic Process
|
78
|
7
|
0.030 |
None |
1.000 |
3 |
|
2009 |
2018 |
TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding)
|
phenotype |
|
Finding
|
12
|
|
0.300 |
None |
1.000 |
2 |
|
2001 |
2010 |
Malignant neoplasm of colon and/or rectum
|
disease |
|
Neoplastic Process
|
3669
|
502
|
0.020 |
None |
1.000 |
2 |
|
2002 |
2002 |
Forced expiratory volume function
|
phenotype |
|
Organ or Tissue Function
|
272
|
1169
|
0.100 |
None |
1.000 |
1 |
3
|
2015 |
2015 |
Progressive Neoplastic Disease
|
phenotype |
|
Neoplastic Process
|
384
|
40
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Progressive cGVHD
|
disease |
|
Disease or Syndrome
|
384
|
40
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
response to bronchodilator
|
phenotype |
|
Organism Function
|
131
|
1106
|
0.100 |
None |
1.000 |
1 |
2
|
2015 |
2015 |
Human immunodeficiency virus (HIV) II infection category B1
|
disease |
|
Disease or Syndrome
|
985
|
56
|
0.010 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Somatic mutation
|
phenotype |
|
Cell or Molecular Dysfunction
|
151
|
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of blood and blood-forming tissues
|
disease |
|
Finding
|
23
|
1
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of metabolism/homeostasis
|
phenotype |
|
Finding
|
171
|
5
|
0.100 |
None |
|
0 |
|
|
|
Impulsive Behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
276
|
69
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Smoking
|
phenotype |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
391
|
765
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Addictive Behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
332
|
56
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Smoking Behaviors
|
phenotype |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
249
|
742
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
NEUROTICISM
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
141
|
54
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Nicotine Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
170
|
178
|
0.400 |
None |
0.957 |
23 |
4
|
1999 |
2020 |
Tobacco Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
34
|
4
|
0.380 |
None |
1.000 |
11 |
|
2000 |
2018 |
Nicotine Use Disorder
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
14
|
|
0.310 |
None |
1.000 |
6 |
|
2004 |
2018 |
Withdrawal Symptoms
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Sign or Symptom
|
126
|
10
|
0.030 |
None |
1.000 |
3 |
|
2006 |
2019 |
Alcoholic Intoxication, Chronic
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
577
|
441
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2018 |
Drug abuse
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
405
|
39
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Drug usage
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
170
|
21
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |